Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Highly immunogenic peptides derived from the human immunodeficiency virus V2 region

Highly immunogenic peptides derived from the human immunodeficiency virus V2 region

US Patent 9969782 · Granted May 15, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant gp120 protein with V1-loop deletion2024
Propeptide fusion comprising a mutated clostridium botulinum neurotoxin and a VH2024
Compositions and methods for treating and preventing autoimmune induced cardiac 2023
Inhibitors of CaMKK2 and uses of same2022
Small molecule malarial Aldolase-TRAP enhancers and glideosome inhibitors2018
Peptides mimicking HIV-1 viral epitopes in the V2 loop for the GP120 surface env2017
Immunogenic polypeptides comprising a modified loop peptide presenting the HIV-12017
Method of treating cancer with modulators of SCFSkp22016
Pharmaceutical compositions and treatment of genetic diseases associated with no2015
Method of treating cancer by inhibition of protein kinase-like endoplasmic retic2015
Immunogen comprising the HIV GP120 V3 loop in a conformation that induces broadl2015
Method for determining co-receptor selectivity of Human Immunodeficiency Virus-12009